Andrew Spokes portfolio, Q2 2026
Farallon Capital Management · 13F for the quarter ending Jun 30, 2026
For Q2 2026, Farallon Capital Management reported $18.5B across 89 US-listed positions, led by RVMD (13.8%), Electronic Arts Inc (8.8%) and BBIO (4.3%). Compared with its filing for Q1 2026, Andrew Spokes opened 21 new positions, added to 30, reduced 24 and sold out of 104; 14 positions did not change.
The largest purchase was an addition to IMVT ($164.1M); the largest sale, a reduction of MSFT ($459.5M).
Key facts
- 13F portfolio value
- $18.5BQ2 2026
- Positions
- 89
- Largest holding
- RVMD 13.8%
- New positions
- 21
- Sold out
- 104
- Filed
- Aug 14, 2026
Holdings as of (Q2 2026), filed with the SEC on and amended on . Changes are measured against the filing for Mar 31, 2026. Every tracked investor's Q2 2026 13F.
Bought and sold in Q2 2026
| Stock | Move | Shares | Size | Of portfolio |
|---|---|---|---|---|
| Microsoft CorpMSFT | ▼ Reduced 53% | −1.23M | $459.5M | 2.49% |
| Amazon.com IncAMZN | ▼ Reduced 38% | −1.59M | $377.9M | 2.05% |
| Aon PLCAON | ▼ Reduced 45% | −1.13M | $374.8M | 2.03% |
| The Charles Schwab CorpSCHW | ▼ Sold out | −3.96M | $371.8M | 2.01% |
| Alphabet IncGOOG | ▼ Sold out | −996.23K | $285.8M | 1.55% |
| Natera IncNTRA | ▼ Reduced 31% | −989K | $268.5M | 1.45% |
| Visa IncV | ▼ Sold out | −840.71K | $254.1M | 1.38% |
| Broadcom IncAVGO | ▼ Reduced 35% | −627.7K | $237.1M | 1.29% |
| The Walt Disney CoDIS | ▼ Sold out | −2.4M | $231.5M | 1.25% |
| UnitedHealth Group IncUNH | ▼ Reduced 30% | −551.17K | $229.1M | 1.24% |
| Kenvue IncKVUE | ▼ Reduced 32% | −11.72M | $224M | 1.21% |
| Mastercard IncMA | ▼ Sold out | −435.07K | $217.4M | 1.18% |
| Mckesson CorpMCK | ▼ Sold out | −234.3K | $202.8M | 1.10% |
| WabtecWAB | ▼ Reduced 44% | −714.9K | $192.7M | 1.04% |
Centessa Pharmaceuticals PLCno ticker on file | ▼ Sold out | −4.81M | $191M | 1.04% |
| Synopsys IncSNPS | ▼ Reduced 32% | −383.7K | $171.2M | 0.93% |
| Immunovant IncIMVT | ▲ Added 275% | +4.26M | $164.1M | 0.89% |
| Roivant Sciences LtdROIV | ▲ Added 48% | +4.63M | $164M | 0.89% |
| AramarkARMK | ▼ Reduced 41% | −2.51M | $142.8M | 0.77% |
Apogee Therapeutics Incno ticker on file | ▲ New | +1.06M | $140.7M | 0.76% |
| Tyra Biosciences IncTYRA | ▼ Sold out | −3.58M | $137.1M | 0.74% |
| Boston Scientific CorpBSX | ▲ Added 41% | +3.05M | $130.2M | 0.71% |
| Bridgebio Pharma IncBBIO | ▲ Added 15% | +1.38M | $102.6M | 0.56% |
| Tango Therapeutics IncTNGX | ▲ Added 35% | +3.18M | $99.4M | 0.54% |
Electronic Arts Incno ticker on file | ▲ Added 6.0% | +449.5K | $92.2M | 0.50% |
| Novo Nordisk A/SNVO | ▲ Added 235% | +1.84M | $88.1M | 0.48% |
| Baidu IncBIDU | ▲ Added 171% | +760K | $86.9M | 0.47% |
| Tenet Healthcare CorpTHC | ▼ Sold out | −452.15K | $85.3M | 0.46% |
| Thermo Fisher Scientific IncTMO | ▲ Added 19% | +167.7K | $84.1M | 0.46% |
| Cardinal Health IncCAH | ▼ Sold out | −368K | $77.8M | 0.42% |
| Acadia Healthcare CompanyACHC | ▲ Added 143% | +2.48M | $73.4M | 0.40% |
| Vaxcyte IncPCVX | ▼ Sold out | −1.26M | $73.3M | 0.40% |
| Twist Bioscience CorpTWST | ▲ Added 50% | +708.75K | $72.9M | 0.40% |
| Dianthus Therapeutics IncDNTH | ▼ Sold out | −836K | $70.2M | 0.38% |
| Johnson & JohnsonJNJ | ▲ Added 176% | +260K | $66M | 0.36% |
| AstraZeneca PLCAZN | ▲ Added 153% | +347.5K | $65.9M | 0.36% |
| Parabilis Medicines IncPBLS | ▲ New | +2.37M | $64.8M | 0.35% |
| Grail IncGRAL | ▲ Added 28% | +907.9K | $62M | 0.34% |
| Novartis AGNVS | ▲ New | +363K | $56.9M | 0.31% |
| KKR & Co. IncKKR | ▼ Reduced 12% | −553.5K | $50.8M | 0.28% |
| Beta Bionics IncBBNX | ▼ Reduced 84% | −3.01M | $47.2M | 0.26% |
| Guardant Health IncGH | ▲ Added more than 10× | +314.2K | $47.1M | 0.26% |
| CG Oncology IncCGON | ▼ Sold out | −674K | $45.6M | 0.25% |
| Welltower IncWELL | ▼ Reduced 100% | −199K | $45.2M | 0.24% |
Strategy Incno ticker on file | ▲ Added 122% | — | $41.5M | 0.22% |
| Avalo Therapeutics IncAVTX | ▲ Added 173% | +1.58M | $29.2M | 0.16% |
| Bitwise 10 Crypto Index ETFBITW | ▼ Sold out | −603K | $26.9M | 0.15% |
| Warby Parker IncWRBY | ▲ New | +828K | $25.1M | 0.14% |
Crinetics Pharmaceuticalsno ticker on file | ▲ Added 7.8% | +651K | $24.4M | 0.13% |
| Kailera Therapeutics IncKLRA | ▲ New | +1.1M | $24.2M | 0.13% |
| Royalty Pharma PLCRPRX | ▼ Sold out | −493K | $23.6M | 0.13% |
| Liquidia CorporationLQDA | ▼ Reduced 3.4% | −291K | $23.2M | 0.13% |
| Maze Therapeutics IncMAZE | ▲ Added 197% | +734.81K | $21.9M | 0.12% |
| NetEase IncNTES | ▼ Reduced 58% | −167.72K | $21.5M | 0.12% |
| Merck & Co. IncMRK | ▼ Reduced 45% | −162K | $20.8M | 0.11% |
| Exelixis IncEXEL | ▲ Added 2.7% | +357K | $19.4M | 0.11% |
| Axalta Coating Systems LtdAXTA | ▲ New | +478K | $16.4M | 0.09% |
| Abivax SAABVX | ▲ Added more than 10× | +120K | $16M | 0.09% |
| Biogen IncBIIB | ▲ New | +71K | $15.3M | 0.08% |
| Taysha Gene Therapies IncTSHA | ▲ New | +2.25M | $15.3M | 0.08% |
| Mobia Med IncMOBI | ▲ New | +1.13M | $15.1M | 0.08% |
Strategy Incno ticker on file | ▲ New | — | $14.2M | 0.08% |
| Ceco Environmental CorpCECO | ▼ Sold out | −234K | $13.9M | 0.08% |
| Alamar Biosciences IncALMR | ▲ New | +462.9K | $12.5M | 0.07% |
| Rio Tinto PLCRIO | ▲ Added 241% | +129.68K | $12.3M | 0.07% |
| GDS Holdings LtdGDS | ▼ Sold out | −292K | $11.8M | 0.06% |
| Vnet Group IncVNET | ▲ Added 220% | +1.37M | $11M | 0.06% |
| Teva Pharmaceutical IndustriesTEVA | ▼ Reduced 89% | −314K | $10.6M | 0.06% |
| Assembly Biosciences IncASMB | ▲ Added 31% | +377K | $10.4M | 0.06% |
| Revolution Medicines IncRVMD | ▼ Reduced 0.4% | −54K | $10.1M | 0.05% |
| Alvotech SAALVO | ▲ Added more than 10× | +2.66M | $9.8M | 0.05% |
| Agios Pharmaceuticals IncAGIO | ▲ Added 4.1% | +233.4K | $8.7M | 0.05% |
| Brightspring Health Services IncBTSG | ▲ Added 7.2% | +115.8K | $8.1M | 0.04% |
| JOYY IncJOYY | ▲ Added 21% | +121K | $8M | 0.04% |
| Inflarx NVIFRX | ▲ New | +3.33M | $7.4M | 0.04% |
| Enanta Pharmaceuticals IncENTA | ▼ Reduced 16% | −453.66K | $6.6M | 0.04% |
| Scotts Miracle-Gro CoSMG | ▲ New | +88K | $6M | 0.03% |
Warner Bros Discovery Incno ticker on file | ▲ Added 0.8% | +210K | $5.6M | 0.03% |
| Formfactor IncFORM | ▼ Sold out | −56.5K | $5.5M | 0.03% |
| Mastec IncMTZ | ▼ Sold out | −17K | $5.5M | 0.03% |
| Waystar Holding CorpWAY | ▲ New | +264.9K | $5.4M | 0.03% |
| Entegris IncENTG | ▼ Sold out | −45.5K | $5.3M | 0.03% |
| Citigroup IncC | ▼ Sold out | −47K | $5.3M | 0.03% |
| Hyatt Hotels CorpH | ▼ Sold out | −36K | $5.2M | 0.03% |
| Western Alliance BancorpWAL | ▼ Sold out | −73K | $5.2M | 0.03% |
| Brunswick CorpBC | ▲ New | +61K | $5.1M | 0.03% |
| Timken CoTKR | ▼ Sold out | −51K | $5.1M | 0.03% |
| Flex LtdFLEX | ▼ Sold out | −78K | $5.1M | 0.03% |
| S&P Global IncSPGI | ▼ Sold out | −12K | $5.1M | 0.03% |
| Littelfuse IncLFUS | ▼ Sold out | −15K | $5.1M | 0.03% |
| Piper Sandler CompaniesPIPR | ▼ Sold out | −66K | $5.1M | 0.03% |
| Aar CorpAIR | ▼ Sold out | −46K | $5M | 0.03% |
| Gentex CorpGNTX | ▲ New | +199K | $5M | 0.03% |
| Garrett Motion IncGTX | ▼ Sold out | −275K | $5M | 0.03% |
| Rollins IncROL | ▼ Sold out | −93K | $5M | 0.03% |
| Affirm Holdings IncAFRM | ▼ Sold out | −108K | $4.9M | 0.03% |
| Inter & Co IncINTR | ▼ Sold out | −614.5K | $4.9M | 0.03% |
| Cummins IncCMI | ▼ Sold out | −9K | $4.8M | 0.03% |
| Fiserv IncFISV | ▼ Sold out | −86K | $4.8M | 0.03% |
| Vertiv Holdings CoVRT | ▼ Sold out | −19K | $4.8M | 0.03% |
| Idexx Labs IncIDXX | ▲ New | +9K | $4.7M | 0.03% |
| Amkor Technology IncAMKR | ▼ Sold out | −104K | $4.7M | 0.03% |
| Atrium Therapeutics IncRNA | ▼ Sold out | −349.36K | $4.7M | 0.03% |
| Globalfoundries IncGFS | ▼ Sold out | −105K | $4.7M | 0.03% |
| Molina Healthcare IncMOH | ▼ Sold out | −35K | $4.7M | 0.03% |
| Opus Genetics IncIRD | ▼ Sold out | −1M | $4.6M | 0.02% |
| Tenable Holdings IncTENB | ▼ Sold out | −265K | $4.5M | 0.02% |
| ServiceNow IncNOW | ▼ Sold out | −41K | $4.3M | 0.02% |
| Commercial Metals CoCMC | ▲ New | +67K | $4.2M | 0.02% |
| Beam Therapeutics IncBEAM | ▲ Added 1.0% | +101.7K | $3.5M | 0.02% |
| Jatt II Acquisition CorpJATT | ▲ New | +300K | $3.4M | 0.02% |
| Sagimet Biosciences IncSGMT | ▲ New | +415K | $3.2M | 0.02% |
Strategy Incno ticker on file | ▲ New | — | $2.3M | 0.01% |
| Madrigal Pharmaceuticals IncMDGL | ▼ Sold out | −3.32K | $1.7M | 0.01% |
| Capricor Therapeutics IncCAPR | ▼ Sold out | −41K | $1.2M | 0.01% |
| Arrowhead PharmaceuticalsARWR | ▼ Sold out | −15.8K | $990.7K | 0.01% |
| Alkermes PLCALKS | ▼ Sold out | −20.8K | $735.5K | 0.00% |
| Axsome Therapeutics IncAXSM | ▼ Sold out | −4K | $676.1K | 0.00% |
| Arcutis Biotherapeutics IncARQT | ▼ Sold out | −26K | $612.6K | 0.00% |
| Celcuity IncCELC | ▼ Sold out | −4K | $456.6K | 0.00% |
| Pacific Biosciences of California IncPACB | ▼ Reduced 89% | −120.8K | $202.9K | 0.00% |
| Rani Therapeutics Holdings-ARANI | ▼ Reduced 73% | −57.3K | $43.6K | 0.00% |
| Geron CorpGERN | ▼ Reduced 67% | −28.6K | $36.6K | 0.00% |
| Canopy Growth CorporationCGC | ▼ Reduced 40% | −12K | $11.4K | 0.00% |
Blue Gold Ltdno ticker on file | ▼ Reduced 15% | −44.2K | $5.3K | 0.00% |
The filing as a whole has 21 new, 30 added, 24 reduced and 104 sold-out positions; listed are the moves among its 89 largest positions and 50 largest exits.
Holdings at the quarter's end
| # | Stock | Sector | Share of portfolio | Value | Shares | Reported price | Held | Since Q1 2026 |
|---|---|---|---|---|---|---|---|---|
| 1 | Revolution Medicines IncRVMD | Health Care | 13.8% | $2.5B | 13.55M | $187.28 | 8+ qtrs | ▼ Reduced 0.4% |
| 2 | Electronic Arts Incno ticker on file | — | 8.80% | $1.6B | 7.92M | $205.04 | 3 qtrs | ▲ Added 6.0% |
| 3 | Bridgebio Pharma IncBBIO | Health Care | 4.34% | $800.1M | 10.74M | $74.48 | 8+ qtrs | ▲ Added 15% |
| 4 | Protagonist Therapeutics IncPTGX | Health Care | 4.22% | $778.2M | 6.35M | $122.58 | 8+ qtrs | No change |
| 5 | Warner Bros Discovery Incno ticker on file | — | 4.06% | $749.1M | 28.1M | $26.66 | 3 qtrs | ▲ Added 0.8% |
| 6 | Exelixis IncEXEL | Health Care | 3.97% | $732.8M | 13.47M | $54.41 | 8+ qtrs | ▲ Added 2.7% |
| 7 | Liquidia CorporationLQDA | — | 3.62% | $666.9M | 8.37M | $79.73 | 8+ qtrs | ▼ Reduced 3.4% |
| 8 | Amazon.com IncAMZN | Consumer Discretionary | 3.40% | $627.5M | 2.63M | $238.34 | 5 qtrs | ▼ Reduced 38% |
| 9 | Lantheus Holdings IncLNTH | Health Care | 3.36% | $619.4M | 5.58M | $110.94 | 8+ qtrs | No change |
| 10 | Natera IncNTRA | Health Care | 3.26% | $602.2M | 2.22M | $271.45 | 8+ qtrs | ▼ Reduced 31% |
| 11 | UnitedHealth Group IncUNH | Health Care | 2.86% | $528.1M | 1.27M | $415.63 | 8+ qtrs | ▼ Reduced 30% |
| 12 | Thermo Fisher Scientific IncTMO | Health Care | 2.85% | $526M | 1.05M | $501.36 | 8+ qtrs | ▲ Added 19% |
| 13 | Roivant Sciences LtdROIV · SHS | Health Care | 2.75% | $506.4M | 14.31M | $35.39 | 8+ qtrs | ▲ Added 48% |
| 14 | Kenvue IncKVUE | — | 2.59% | $478M | 25.02M | $19.11 | 3 qtrs | ▼ Reduced 32% |
| 15 | Aon PLCAON · SHS CL A | Financials | 2.49% | $458.6M | 1.38M | $331.69 | 8+ qtrs | ▼ Reduced 45% |
| 16 | Boston Scientific CorpBSX | Health Care | 2.43% | $449M | 10.52M | $42.68 | 8+ qtrs | ▲ Added 41% |
| 17 | Broadcom IncAVGO | Technology | 2.36% | $435.1M | 1.15M | $377.75 | 3 qtrs | ▼ Reduced 35% |
| 18 | Microsoft CorpMSFT | Technology | 2.25% | $415.1M | 1.11M | $373.02 | 8+ qtrs | ▼ Reduced 53% |
| 19 | Tango Therapeutics IncTNGX | — | 2.08% | $383.8M | 12.28M | $31.26 | 7 qtrs | ▲ Added 35% |
| 20 | KKR & Co. IncKKR | Financials | 2.05% | $378M | 4.12M | $91.78 | 3 qtrs | ▼ Reduced 12% |
| 21 | Synopsys IncSNPS | Technology | 2.01% | $370.1M | 829.6K | $446.07 | 3 qtrs | ▼ Reduced 32% |
| 22 | Beam Therapeutics IncBEAM | — | 1.90% | $351.3M | 10.24M | $34.32 | 8+ qtrs | ▲ Added 1.0% |
| 23 | Crinetics Pharmaceuticalsno ticker on file | — | 1.82% | $336.4M | 8.99M | $37.42 | 8+ qtrs | ▲ Added 7.8% |
| 24 | Grail IncGRAL | Health Care | 1.54% | $284.1M | 4.16M | $68.27 | 5 qtrs | ▲ Added 28% |
| 25 | WabtecWAB | Industrials | 1.31% | $241.2M | 894.5K | $269.60 | 8+ qtrs | ▼ Reduced 44% |
| 26 | Immunovant IncIMVT | Health Care | 1.21% | $223.7M | 5.81M | $38.53 | 8+ qtrs | ▲ Added 275% |
| 27 | Twist Bioscience CorpTWST | Health Care | 1.19% | $219.8M | 2.14M | $102.88 | 8+ qtrs | ▲ Added 50% |
| 28 | Agios Pharmaceuticals IncAGIO | — | 1.19% | $219.6M | 5.92M | $37.11 | 8+ qtrs | ▲ Added 4.1% |
| 29 | AramarkARMK | Consumer Discretionary | 1.12% | $206.3M | 3.63M | $56.90 | 8+ qtrs | ▼ Reduced 41% |
| 30 | Apogee Therapeutics Incno ticker on file | — | 0.76% | $140.7M | 1.06M | $132.73 | 1 qtr | New |
| 31 | Baidu IncBIDU · SPON ADR REP A | Technology | 0.75% | $137.6M | 1.2M | $114.29 | 4 qtrs | ▲ Added 171% |
| 32 | Novo Nordisk A/SNVO · ADR | Health Care | 0.68% | $125.6M | 2.62M | $47.94 | 2 qtrs | ▲ Added 235% |
| 33 | Acadia Healthcare CompanyACHC | — | 0.68% | $124.6M | 4.22M | $29.53 | 2 qtrs | ▲ Added 143% |
| 34 | Brightspring Health Services IncBTSG | Health Care | 0.66% | $120.8M | 1.73M | $69.74 | 8+ qtrs | ▲ Added 7.2% |
| 35 | AstraZeneca PLCAZN · ORD | Health Care | 0.59% | $108.8M | 574K | $189.62 | 2 qtrs | ▲ Added 153% |
| 36 | Johnson & JohnsonJNJ | Health Care | 0.56% | $103.6M | 408K | $253.97 | 2 qtrs | ▲ Added 176% |
| 37 | Strategy Incno ticker on file · NOTE 12/0 | — | 0.41% | $75.4M | — | — | 2 qtrs | ▲ Added 122% |
| 38 | Parabilis Medicines IncPBLS | — | 0.35% | $64.8M | 2.37M | $27.37 | 1 qtr | New |
| 39 | Novartis AGNVS · SPONSORED ADR | Health Care | 0.31% | $56.9M | 363K | $156.72 | 1 qtr | New |
| 40 | Guardant Health IncGH | Health Care | 0.26% | $48.3M | 322.2K | $150.03 | 5 qtrs | ▲ Added more than 10× |
| 41 | Vnet Group Incno ticker on file · NOTE 2.000%10/0 | — | 0.25% | $46.8M | — | — | 2 qtrs | No change |
| 42 | Avalo Therapeutics IncAVTX | — | 0.25% | $46.2M | 2.5M | $18.48 | 2 qtrs | ▲ Added 173% |
| 43 | JOYY IncJOYY · ADS REPSTG COM A | — | 0.25% | $46.1M | 699.2K | $65.99 | 6 qtrs | ▲ Added 21% |
| 44 | Assembly Biosciences IncASMB | — | 0.24% | $44.1M | 1.6M | $27.48 | 4 qtrs | ▲ Added 31% |
| 45 | Enanta Pharmaceuticals IncENTA | — | 0.19% | $35.3M | 2.42M | $14.58 | 8+ qtrs | ▼ Reduced 16% |
| 46 | Maze Therapeutics IncMAZE | — | 0.18% | $33.1M | 1.11M | $29.84 | 2 qtrs | ▲ Added 197% |
| 47 | Merck & Co. IncMRK | Health Care | 0.14% | $25.6M | 199K | $128.50 | 2 qtrs | ▼ Reduced 45% |
| 48 | Warby Parker IncWRBY · CL A COM | — | 0.14% | $25.1M | 828K | $30.34 | 1 qtr | New |
| 49 | Perceptive Cap Solutionsno ticker on file · CL A ORD SHS | — | 0.13% | $24.5M | 2.25M | $10.88 | 3 qtrs | No change |
| 50 | Kailera Therapeutics IncKLRA | — | 0.13% | $24.2M | 1.1M | $22.03 | 1 qtr | New |
| 51 | Rio Tinto PLCRIO · SPONSORED ADR | Materials | 0.09% | $17.4M | 183.48K | $94.93 | 2 qtrs | ▲ Added 241% |
| 52 | Axalta Coating Systems LtdAXTA | Materials | 0.09% | $16.4M | 478K | $34.22 | 1 qtr | New |
| 53 | Abivax SAABVX · SPONSORED ADS | Health Care | 0.09% | $16.3M | 122K | $133.26 | 4 qtrs | ▲ Added more than 10× |
| 54 | Vnet Group IncVNET · SPONSORED ADS A | — | 0.09% | $16M | 1.99M | $8.04 | 8+ qtrs | ▲ Added 220% |
| 55 | NetEase IncNTES · SPONSORED ADS | Technology | 0.09% | $15.8M | 123.5K | $128.14 | 2 qtrs | ▼ Reduced 58% |
| 56 | Biogen IncBIIB | Health Care | 0.08% | $15.3M | 71K | $216.06 | 1 qtr | New |
| 57 | Taysha Gene Therapies IncTSHA | — | 0.08% | $15.3M | 2.25M | $6.81 | 1 qtr | New |
| 58 | Mobia Med IncMOBI | — | 0.08% | $15.1M | 1.13M | $13.40 | 1 qtr | New |
| 59 | Strategy Incno ticker on file · NOTE 2.250% 6/1 | — | 0.08% | $14.2M | — | — | 1 qtr | New |
| 60 | Minerva Neurosciences IncNERV | — | 0.07% | $13.1M | 2.37M | $5.55 | 3 qtrs | No change |
| 61 | Alamar Biosciences IncALMR | — | 0.07% | $12.5M | 462.9K | $27.09 | 1 qtr | New |
| 62 | Alvotech SAALVO · ORDINARY SHARES | — | 0.06% | $10.6M | 2.86M | $3.69 | 8+ qtrs | ▲ Added more than 10× |
| 63 | Beta Bionics IncBBNX | — | 0.05% | $9.3M | 595K | $15.67 | 6 qtrs | ▼ Reduced 84% |
| 64 | Inflarx NVIFRX | — | 0.04% | $7.4M | 3.33M | $2.24 | 1 qtr | New |
| 65 | Scotts Miracle-Gro CoSMG · CL A | — | 0.03% | $6M | 88K | $68.11 | 1 qtr | New |
| 66 | Waystar Holding CorpWAY | Technology | 0.03% | $5.4M | 264.9K | $20.53 | 1 qtr | New |
| 67 | Brunswick CorpBC | Industrials | 0.03% | $5.1M | 61K | $84.24 | 1 qtr | New |
| 68 | Gentex CorpGNTX | — | 0.03% | $5M | 199K | $25.27 | 1 qtr | New |
| 69 | Idexx Labs IncIDXX | Health Care | 0.03% | $4.7M | 9K | $526.44 | 1 qtr | New |
| 70 | Prime Medicine IncPRME | — | 0.03% | $4.6M | 1.24M | $3.69 | 8+ qtrs | No change |
| 71 | Commercial Metals CoCMC | Materials | 0.02% | $4.2M | 67K | $62.75 | 1 qtr | New |
| 72 | Jatt II Acquisition CorpJATT · ORD SHS | — | 0.02% | $3.4M | 300K | $11.36 | 1 qtr | New |
| 73 | Sagimet Biosciences IncSGMT | — | 0.02% | $3.2M | 415K | $7.73 | 1 qtr | New |
| 74 | Strategy Incno ticker on file · NOTE 3/0 | — | 0.01% | $2.3M | — | — | 1 qtr | New |
| 75 | Summit Midstream CorporationSMC | — | 0.01% | $1.7M | 58.21K | $28.48 | 8+ qtrs | No change |
| 76 | Teva Pharmaceutical IndustriesTEVA · SPONSORED ADS | Health Care | 0.01% | $1.4M | 40K | $33.88 | 4 qtrs | ▼ Reduced 89% |
| 77 | Revolution Medicines Incno ticker on file · *W EXP 12/17/202 | — | 0.01% | $1.1M | 120.09K | $9.40 | 8+ qtrs | No change |
| 78 | Cogent Biosciences IncCOGT | Health Care | 0.00% | $657.9K | 17K | $38.70 | 8+ qtrs | No change |
| 79 | Aleanna Incno ticker on file · *W EXP 12/13/202 | — | 0.00% | $297K | 990K | $0.3000 | 7 qtrs | No change |
| 80 | Aleanna Incno ticker on file | — | 0.00% | $227.4K | 78.4K | $2.90 | 7 qtrs | No change |
| 81 | Welltower IncWELL | Real Estate | 0.00% | $227K | 1K | $226.97 | 3 qtrs | ▼ Reduced 100% |
| 82 | Solid Power Incno ticker on file · *W EXP 12/08/202 | — | 0.00% | $41.4K | 405.32K | $0.1022 | 8+ qtrs | No change |
| 83 | Blue Gold Ltdno ticker on file · *W EXP 04/01/203 | — | 0.00% | $30.7K | 255.8K | $0.1200 | 4 qtrs | ▼ Reduced 15% |
| 84 | Pacific Biosciences of California IncPACB | — | 0.00% | $23.9K | 14.2K | $1.68 | 8+ qtrs | ▼ Reduced 89% |
| 85 | Geron CorpGERN | — | 0.00% | $18.4K | 14.4K | $1.28 | 8+ qtrs | ▼ Reduced 67% |
| 86 | Nvni Group Limitedno ticker on file · *W EXP 11/01/202 | — | 0.00% | $17.6K | 375K | $0.0468 | 8+ qtrs | No change |
| 87 | Canopy Growth CorporationCGC | — | 0.00% | $17.1K | 18K | $0.9500 | 8+ qtrs | ▼ Reduced 40% |
| 88 | Rani Therapeutics Holdings-ARANI | — | 0.00% | $15.7K | 20.7K | $0.7604 | 3 qtrs | ▼ Reduced 73% |
| 89 | Beyond Meat IncBYND | — | 0.00% | $14.3K | 19K | $0.7500 | 8+ qtrs | No change |
By sector
| Sector | Share of portfolio | Value | Positions |
|---|---|---|---|
| Health Care | 51.1% | $9.4B | 25 |
| Technology | 7.47% | $1.4B | 6 |
| Financials | 4.53% | $836.6M | 2 |
| Consumer Discretionary | 4.52% | $833.9M | 2 |
| Industrials | 1.33% | $246.3M | 2 |
| Materials | 0.21% | $38M | 3 |
| Real Estate | 0.00% | $227K | 1 |
| No sector on file | 30.8% | $5.7B | 48 |
Questions and answers
What did Andrew Spokes own in Q2 2026?
Farallon Capital Management's 13F for Q2 2026 lists 89 positions worth $18.5B. The largest: RVMD (13.8%), Electronic Arts Inc (8.8%), BBIO (4.3%), PTGX (4.2%), Warner Bros Discovery Inc (4.1%).
What did Andrew Spokes buy in Q2 2026?
The largest purchases, by the shares bought at the quarter-end price the filing implies: IMVT (added, $164.1M), ROIV (added, $164M), Apogee Therapeutics Inc (new, $140.7M), BSX (added, $130.2M), BBIO (added, $102.6M), TNGX (added, $99.4M).
What did Andrew Spokes sell in Q2 2026?
The largest sales: MSFT (reduced, $459.5M), AMZN (reduced, $377.9M), AON (reduced, $374.8M), SCHW (sold out, $371.8M), GOOG (sold out, $285.8M), NTRA (reduced, $268.5M).
When was this filing made?
Farallon Capital Management filed its 13F for the quarter ending Jun 30, 2026 on Aug 14, 2026, and amended it on Nov 16, 2026; the figures here include the amendment. A 13F is due within 45 days of the quarter's end, so the positions were already weeks old when it became public.
Learn
Cite this page
Funkfolio, “Andrew Spokes portfolio, Q2 2026: Farallon Capital Management 13F holdings”, data as of 16 November 2026. https://funkfolio.com/gurus/farallon/2026-q2
Underlying data: SEC EDGAR, Form 13F-HR of Farallon Capital Management (CIK 909661) for the period ending Jun 30, 2026.
Source: SEC EDGAR, Form 13F-HR for Farallon Capital Management (CIK 909661), period ending Jun 30, 2026, filed Aug 14, 2026, amended Nov 16, 2026. Changes compare share counts with the filing for Mar 31, 2026; a share split in between is allowed for where one is on record. “Reported price” is a position's reported value divided by its shares. The size of a buy or sell is the change in shares at that price; a position sold out is sized at its value in the previous filing, and “of portfolio” sets the size against the $18.5B reported for this quarter. “Held” counts consecutive quarterly filings up to this one, out of the 8 looked at from here back. Sectors are those of the ranked companies on this site as they stand today. 3 option positions in the filing are not shown. Not a live portfolio and not advice.